Expression of somatostatin receptors in hepatocellular carcinoma.

Hepatocellular carcinoma (HCC) is a prevalent malignant liver tumour worldwide.Somatostatin receptors (SSTR) are expressed in HCC and can be detected and applied in nuclear medicine. But small and early tumours are difficult to pick up radiologically. Little is known about the difference of using ge...

Full description

Bibliographic Details
Main Author: Tan, Hock Jin.
Other Authors: School of Biological Sciences
Format: Final Year Project (FYP)
Language:English
Published: 2011
Subjects:
Online Access:http://hdl.handle.net/10356/42862
_version_ 1811686174484332544
author Tan, Hock Jin.
author2 School of Biological Sciences
author_facet School of Biological Sciences
Tan, Hock Jin.
author_sort Tan, Hock Jin.
collection NTU
description Hepatocellular carcinoma (HCC) is a prevalent malignant liver tumour worldwide.Somatostatin receptors (SSTR) are expressed in HCC and can be detected and applied in nuclear medicine. But small and early tumours are difficult to pick up radiologically. Little is known about the difference of using generic anti-somatostatin and SSTR subtype-specific antibodies in immunohistochemical detection of SSTR. Study on SSTR expression pattern that corresponds to beneficial clinical effect is still lacking.Expression of somatostatin receptor in 59 HCC cases was analyzed by immunohistochemistry using the rabbit anti-somatostatin and rabbit polyclonal to SSTR subtype 1-5. Survival outcome was constructed by Kaplan Meier method and compared using Log Rank Test. The commonly used anti-somatostatin is highly sensitive to detect SSTR compared with the subtype-specific stains. The mean expression (IPS) for SSTR1, SSTR2, SSTR3, SSTR4 and SSTR5 is 60, 10.25, 36.7, 111.9 and 96.6 respectively. No significant correlation was observed between SSTR expression and tumours’ Edmondson grade, size, capsulation and vascular invasion. Kaplan Meier curves showed that SSTR1, 4 and 5 positivity impact adversely on Disease Free Survival although it is not statistically significant.Generic anti-somatostatin antibody is useful in SSTR immunohistochemical detection. Analysis of SSTR expression pattern and its expression levels in individual patient might contribute to more accurate and sensitive radionuclide tests and increased treatment efficacy.
first_indexed 2024-10-01T04:56:13Z
format Final Year Project (FYP)
id ntu-10356/42862
institution Nanyang Technological University
language English
last_indexed 2024-10-01T04:56:13Z
publishDate 2011
record_format dspace
spelling ntu-10356/428622023-02-28T18:07:26Z Expression of somatostatin receptors in hepatocellular carcinoma. Tan, Hock Jin. School of Biological Sciences Lim Kiat Hon DRNTU::Science::Biological sciences::Human anatomy and physiology::Endocrinology Hepatocellular carcinoma (HCC) is a prevalent malignant liver tumour worldwide.Somatostatin receptors (SSTR) are expressed in HCC and can be detected and applied in nuclear medicine. But small and early tumours are difficult to pick up radiologically. Little is known about the difference of using generic anti-somatostatin and SSTR subtype-specific antibodies in immunohistochemical detection of SSTR. Study on SSTR expression pattern that corresponds to beneficial clinical effect is still lacking.Expression of somatostatin receptor in 59 HCC cases was analyzed by immunohistochemistry using the rabbit anti-somatostatin and rabbit polyclonal to SSTR subtype 1-5. Survival outcome was constructed by Kaplan Meier method and compared using Log Rank Test. The commonly used anti-somatostatin is highly sensitive to detect SSTR compared with the subtype-specific stains. The mean expression (IPS) for SSTR1, SSTR2, SSTR3, SSTR4 and SSTR5 is 60, 10.25, 36.7, 111.9 and 96.6 respectively. No significant correlation was observed between SSTR expression and tumours’ Edmondson grade, size, capsulation and vascular invasion. Kaplan Meier curves showed that SSTR1, 4 and 5 positivity impact adversely on Disease Free Survival although it is not statistically significant.Generic anti-somatostatin antibody is useful in SSTR immunohistochemical detection. Analysis of SSTR expression pattern and its expression levels in individual patient might contribute to more accurate and sensitive radionuclide tests and increased treatment efficacy. Bachelor of Science in Biological Sciences 2011-01-24T04:50:58Z 2011-01-24T04:50:58Z 2010 2010 Final Year Project (FYP) http://hdl.handle.net/10356/42862 en Nanyang Technological University 28 p. application/pdf
spellingShingle DRNTU::Science::Biological sciences::Human anatomy and physiology::Endocrinology
Tan, Hock Jin.
Expression of somatostatin receptors in hepatocellular carcinoma.
title Expression of somatostatin receptors in hepatocellular carcinoma.
title_full Expression of somatostatin receptors in hepatocellular carcinoma.
title_fullStr Expression of somatostatin receptors in hepatocellular carcinoma.
title_full_unstemmed Expression of somatostatin receptors in hepatocellular carcinoma.
title_short Expression of somatostatin receptors in hepatocellular carcinoma.
title_sort expression of somatostatin receptors in hepatocellular carcinoma
topic DRNTU::Science::Biological sciences::Human anatomy and physiology::Endocrinology
url http://hdl.handle.net/10356/42862
work_keys_str_mv AT tanhockjin expressionofsomatostatinreceptorsinhepatocellularcarcinoma